ANAB vs CSX · rev $234.6M vs P/E 19, rev $7.42B
AnaptysBio Inc (ANAB) versus CSX Corporation (CSX) — a side-by-side from cached financials, not a winner call.
AnaptysBio Inc (ANAB) is a biotechnology company listed on NASDAQ.
CSX Corporation (CSX) is a railroads company listed on US.
Latest reported ANAB revenue for 2025-12-31 was $234.6M. Net income was -$13.2M. Revenue was up 157.0% from 2024-12-31 to 2025-12-31. ANAB currently screens at market cap $1.62B.
Latest reported CSX revenue for 2026-06-30 was $7.42B. Net income was $1.81B. CSX currently screens at market cap $61.18B and trailing P/E 19.4.
ANAB currently screens at market cap $1.62B. CSX currently screens at market cap $61.18B and trailing P/E 19.4.
Not investment advice. Open the ANAB and CSX stock pages for the full models.
Not investment advice.